Document is current
Any future updates will be listed below
-
Authors
Farkas, Henriette
Máj, Csilla
Kenessey, István
Sebestyén, Anna
Krencz, Ildikó
Pápay, Judit
Cervenak, László https://orcid.org/0000-0003-0166-8697
-
Funding
Funding for this research was provided by:
Nemzeti Kutatási, Fejlesztési és Innovaciós Alap (K124557)
Shire
Semmelweis University
- License Information
-
More Information
Article History
Received: 25 March 2022
Accepted: 16 June 2022
First Online: 4 July 2022
Declarations
:
: The study protocol was approved by the institutional review board of Semmelweis University of Budapest (Reg. No. 1067-5/2018/EUIG).
: No similar data has been or will be published or submitted elsewhere while our manuscript is under consideration at allergy, asthma and clinical immunology.
: Henriette Farkas has received research grants from CSL Behring, Shire/Takeda and Pharming and served as an advisor for these companies and BioCryst, Kalvista and Ono Pharmaceutical. László Cervenak has served as an advisor for Ono Pharmaceutical. Other authors declare no conflict of interest.
